KaydedilenlerDerginizi ekleyin

Dergiler / Journal of the Turkish-German Gynecological Association / 2018 / Cilt: 19 - Sayı: 1

Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost

Serdar ÜNLÜ
Zehra KURDOĞLU
Danielle CARR
Jihad HARMOUCHE
Gökhan S. KILIÇ
Sayfa
7–10
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The number of urinary symptoms and follow-up visits significantly decreased after PTNS (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Overactive bladder (OAB) affects 16.9% of women in the United States.
📊
Temel Bulgular & Veri:Material and Methods: We reviewed 60 women with refractory OAB treated with PTNS.
💡
Sonuç & Katkı:The number of urinary symptoms and follow-up visits significantly decreased after PTNS (p
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Overactive bladder (OAB) affects 16.9% of women in the United States. Percutaneous tibial nerve stimulation (PTNS) is a third-line treatment for patients who are refractory to behavioral and pharmacologic therapies. We aimed to evaluate the effects of PTNS on urinary symptoms in patients diagnosed as having refractory OAB and investigate the cost of medications and clinical visits before and after PTNS treatment. Material and Methods: We reviewed 60 women with refractory OAB treated with PTNS. Episodes of urinary frequency, leakage, urgency, and nocturia; number of follow-up visits; and medications were recorded. The mean quarterly drug, physician, nurse, and provider costs were calculated. The episodes of urinary symptoms, numbers of follow-up visits, and costs of medications and visits before and after PTNS were compared. Results: Of the 60 patients with refractory OAB, 24 patients who completed 12 weekly sessions of initial PTNS were evaluated. The number of urinary symptoms and follow-up visits significantly decreased after PTNS (p

🔖

Bu Makaleye Atıf Yap

ÜNLÜ, S., KURDOĞLU, Z., CARR, D., HARMOUCHE, J., KILIÇ, G. S. (2022). Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost. Journal of the Turkish-German Gynecological Association, Cilt: 19 - Sayı: 1, 7–10. https://ajindex.com/articles/652609

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61: 37-49
  2. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760-6
  3. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50: 1306-14
  4. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011; 77: 1081-7
  5. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-36
  6. Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological A, Society of Urodynamics FPM. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 2015; 193: 1572-80
  7. Gupta P, Ehlert MJ, Sirls LT, Peters KM. Percutaneous tibial nerve stimulation and sacral neuromodulation: an update. Curr Urol Rep 2015; 16: 4
  8. Osman NI, Chapple CR. Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approaches. Arab J Urol 2013; 11: 313-8
  9. Norton C. OAB Evidence from the Patient’s Perspective. European Urology Supplements 2003; 2: 16-22
  10. Congregado Ruiz B, Pena Outeiriño XM, Campoy Martínez P, León Dueñas E, Leal López A. Peripheral Afferent Nerve Stimulation for Treatment of Lower Urinary Tract Irritative Symptoms. Eur Urol 2004; 45: 65-9. 11. van Balken MR, Vandoninck V, Gisolf KW, Vergunst H, Kiemeney LA, Debruyne FM, et al. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol 2001; 166: 914-8
  11. Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial. J Urol 2010; 183: 1438-43
  12. Ganz ML, Smalarz AM, Krupski TL, Anger JT, Hu JC, Wittrup-Jensen KU, et al. Economic